Compositions and methods for treating CNS disorders
US10870677B2 · kind B2 · utility
10Cited by
34References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 26, 2019 |
| Grant date | Dec 22, 2020 |
| Priority date | — |
| Expiry date | Mar 26, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J75/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are neuroactive steroids of the Formula (I): or a pharmaceutically acceptable said thereof; wherein, R1, R2a, R2b, R3 and A are as defined herein. Such compounds are envisioned, in certain embodiments, to behave as GABA modulators. The present invention also provides pharmaceutical compositions comprising a compound of the present invention and methods of use and treatment, e.g., such for inducing sedation and/or anesthesia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.